At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
4 g prescription omega-3 concentrate +1 moredrug
Likely dose
4 g prescription omega-3 concentratefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of a Prescription Omega-3 Fatty Acid Concentrate in a Placebo-controlled Trial of Human Endotoxemia
In Brief
A clinical study evaluating 4 g prescription omega-3 concentrate and Placebo for Inflammatory Responses. Completed, enrolled 21 participants across 1 site.
Detailed Summary
The purpose of this study is to assess whether the marine omega-3 fatty acids can attenuate inflammatory responses to endotoxin challenge.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Responses
CountriesUnited States
CollaboratorsPronova BioPharma
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 2013
Enrollment StartMay 2014
Primary CompletionApr 2015
TodayJul 2026
First PostedMar 18, 2013
Enrollment StartMay 1, 2014
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.3 years ago
Interventions
4 g prescription omega-3 concentratedrug
4 g/d prescription omega-3 fatty acid concentrate taken orally for 8-12 weeks
Placebodrug
olive oil